Olena Karpenko

Dr. Olena Karpenko

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2008 in Current Microbiology
Verified
Journal Article
Closed access
PDF file
ASA. V. Sotirova
A. V. Sotirova
DSD. I. Spasova
D. I. Spasova
DGD. N. Galabova
D. N. Galabova
EKE. Karpenko
E. Karpenko
ASA. Shulga
A. Shulga

1 February 2017 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
IKIlona Kłosowska-Chomiczewska
Ilona Kłosowska-Chomiczewska
KMK. Mędrzycka
K. Mędrzycka
EHE. Hallmann
E. Hallmann
EKE. Karpenko
E. Karpenko
TPTetiana Pokynbroda
Tetiana Pokynbroda
Christian JungnickelChristian Jungnickel
Christian Jungnickel

1 February 2008 in Zeitschrift für Naturforschung C
Verified
Journal Article
Open access
PDF file
MRMimi Remichkova
Mimi Remichkova
DGDanka Galabova
Danka Galabova
IRIvana Roeva
Ivana Roeva
EKElena Karpenko
Elena Karpenko
ASAlexander Shulga
Alexander Shulga
AGAngel S. Galabov
Angel S. Galabov
The rhamnolipid biosurfactant PS-17 and its complex with the polysaccharide alginate, both produced by the Pseudomonas sp. S-17 strain, were studied for their antiviral activity against herpes simplex virus (HSV) types 1 and 2. They significantly inhibited the herpesvirus cytopathic effect (CPE) in the Madin-Darby bovine kidney (MDBK) cell line. The investigations were carried out according to the CPE inhibition assay protocol. The suppressive effect of the compounds on HSV replication was dose-dependent and occurred at concentrations lower than the critical micelle concentration of the surfactant. The 50% inhibitory concentration (IC50) of rhamnolipid PS-17 was 14.5 μg/ml against HSV-1 and 13 μg/ml against HSV-2. The IC50 values of the complex were 435 μg/ml for HSV-1 and 482 μg/ml for HSV-2. The inhibitory effects of the substances were confirmed by measuring the infectious virus yields with the multicycle virus growth experimental design as well: ∆log CCID50 of 1.84−2.0 against the two types of herpes simplex viruses by rhamnolipid PS-17 (20 μg/ml), and a strong reduction of the HSV-2 virus yield under the effect of the alginate complex at a concentration of 450 μg/ml. The results indicate that rhamnolipid PS-17 and its alginate complex may be considered as promising substances for the development of anti-herpetic compounds.

19 July 2012 in Current Microbiology
Verified
Journal Article
Closed access
PDF file
ASAnna Sotirova
Anna Sotirova
TATatyana Avramova
Tatyana Avramova
SSStoyanka Stoitsova
Stoyanka Stoitsova
ILIrina Lazarkevich
Irina Lazarkevich
VLVera Lubenets
Vera Lubenets
DGDanka Galabova
Danka Galabova

1 December 2008 in International Biodeterioration & Biodegradation
Verified
Journal Article
Closed access
TATatyana Avramova
Tatyana Avramova
ASAnna Sotirova
Anna Sotirova
DGDanka Galabova
Danka Galabova
EKElena Karpenko
Elena Karpenko

1 September 2004 in Applied Biochemistry and Microbiology
Verified
Journal Article
Closed access
PDF file
TPT. P. Pirog
T. P. Pirog
TST. A. Shevchuk
T. A. Shevchuk
IVI. N. Voloshina
I. N. Voloshina
EKE. V. Karpenko
E. V. Karpenko